Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,064 | 14,395 | 16,498 | 19,093 | 20,831 |
| Receivables | N/A | N/A | 70 | 70 | 70 |
| TOTAL | $13,961 | $16,384 | $18,327 | $20,670 | $22,566 |
| Non-Current Assets | |||||
| Intangibles | 7,662 | 7,860 | 8,057 | 8,254 | 8,450 |
| Other Non-Current Assets | 34 | 57 | 80 | 101 | 123 |
| TOTAL | $7,697 | $7,917 | $8,136 | $8,355 | $8,572 |
| Total Assets | $21,658 | $24,301 | $26,464 | $29,025 | $31,138 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 648 | 316 | 219 | 355 | 288 |
| Accrued Expenses | 307 | 293 | 279 | 379 | 369 |
| Other current liabilities | 589 | 400 | 402 | 400 | 412 |
| TOTAL | $1,571 | $1,058 | $971 | $1,226 | $1,161 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5 | 6 | 7 | 409 | 431 |
| TOTAL | $5 | $6 | $7 | $591 | $735 |
| Total Liabilities | $1,576 | $1,064 | $978 | $1,817 | $1,896 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32 | 32 | 32 | 31 | 31 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -45,215 | -40,051 | -36,823 | -33,640 | -30,652 |
| Other shareholders' equity | -300 | -300 | 0 | 0 | 0 |
| TOTAL | $20,082 | $23,237 | $25,485 | $27,208 | $29,242 |
| Total Liabilities And Equity | $21,658 | $24,301 | $26,464 | $29,025 | $31,138 |